Zomedica (NYSEAMERICAN:ZOM) Stock Price Down 5.5%

Zomedica Corp. (NYSEAMERICAN:ZOM) was down 5.5% during mid-day trading on Thursday . The stock traded as low as $0.14 and last traded at $0.15. Approximately 6,710,856 shares traded hands during trading, an increase of 36% from the average daily volume of 4,936,473 shares. The stock had previously closed at $0.16.

Zomedica Price Performance

The firm has a market cap of $137.49 million, a PE ratio of -3.51 and a beta of 0.97.

Insider Buying and Selling at Zomedica

In other news, VP Russell Kevin Klass purchased 299,993 shares of the business’s stock in a transaction on Wednesday, June 12th. The shares were acquired at an average cost of $0.16 per share, with a total value of $47,998.88. Following the completion of the acquisition, the vice president now owns 2,000,050 shares of the company’s stock, valued at $320,008. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 4.19% of the company’s stock.

Institutional Investors Weigh In On Zomedica

Large investors have recently modified their holdings of the business. Price T Rowe Associates Inc. MD increased its position in shares of Zomedica by 41.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 948,300 shares of the company’s stock valued at $139,000 after acquiring an additional 276,100 shares during the period. Frazier Financial Advisors LLC purchased a new stake in Zomedica during the 4th quarter valued at about $50,000. Sequoia Financial Advisors LLC acquired a new position in shares of Zomedica in the fourth quarter valued at about $43,000. Finally, Virtu Financial LLC raised its stake in shares of Zomedica by 1,585.0% in the first quarter. Virtu Financial LLC now owns 168,773 shares of the company’s stock worth $25,000 after purchasing an additional 158,757 shares during the last quarter. Hedge funds and other institutional investors own 8.95% of the company’s stock.

Zomedica Company Profile

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.